2021
DOI: 10.1016/j.micpath.2021.105150
|View full text |Cite
|
Sign up to set email alerts
|

Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(10 citation statements)
references
References 89 publications
0
10
0
Order By: Relevance
“…Moreover, antiviral peptides (AVPs) have the potential to block a virus’ cycle at different levels from viral attachment to the host cell to its replication. Some AVPs have natural origins [ [4] , [5] , [6] , [7] ] while others are discovered or rationally designed by bioinformatics techniques machine learning [ [8] , [9] , [10] , [11] ]. Since the outbreak of COVID-19, which is caused by the SARS-CoV-2 virus, peptide inhibitors have also been among the promising anti-covid agents from various resources [ 12 ].…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, antiviral peptides (AVPs) have the potential to block a virus’ cycle at different levels from viral attachment to the host cell to its replication. Some AVPs have natural origins [ [4] , [5] , [6] , [7] ] while others are discovered or rationally designed by bioinformatics techniques machine learning [ [8] , [9] , [10] , [11] ]. Since the outbreak of COVID-19, which is caused by the SARS-CoV-2 virus, peptide inhibitors have also been among the promising anti-covid agents from various resources [ 12 ].…”
Section: Introductionmentioning
confidence: 99%
“…Multi-epitope-based vaccines were preferred over conventional vaccines due to their cost-effectiveness, superior safety, and the ability to tailor epitopes intelligently for increased potency [89], [90]. Several previous studies have employed similar approaches to design multi-epitope vaccine, however, unlike our present studies, they targeted a particular strain of Salmonella [91]–[94]. Here, to develop a pan- Salmonella vaccine, we targeted the core proteome of Salmonella to design a vaccine that will be effective against a broad spectrum of Salmonella infections.…”
Section: Discussionmentioning
confidence: 99%
“…A multi-epitope-based vaccine construct consists of several probable antigenic immunodominant epitopes; hence, such a vaccine can be considered an ideal approach to tackling many bacterial diseases [ 39 ]. During the multi-epitope vaccine construction phase, all the probable antigens that are non-allergic, non-toxin and have good water-soluble capacity were linked with each other through specific GPGPG linkers [ 40 ], and fused with an adjuvant (Cholera toxin B-subunit adjuvant) via an EAAAK linker in order to make the vaccine construct more potent [ 41 ].…”
Section: Methodsmentioning
confidence: 99%